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A B S T R A C T
Coronary computed tomography angiography (CCTA) is a non-invasive alternative to 
invasive coronary angiography, which is highly reliable to rule out obstructive coro-
nary artery disease. It has also been proposed and used for the assessment of patients 
with acute chest pain in the emergency department setting. Recently the results of a 
multicenter randomized trial, the CT-STAT (Coronary Computed Tomographic An-
giography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial have 
been published. In the present article the main messages of this important study will 
be presented and discussed.
I N T R O D U C T I O N
In the USA more than 8 million patients present every year in the emergency 
department (ED) with chest pain suspicious of ischemia.2 Acute coronary syndrome 
(ACS) has to be ruled out in these patients. However, a small percentage of “low risk” 
patients (according to TIMI risk score) are actually suffering from coronary artery 
disease (CAD).3 Emergency room triage based mainly on history, serial electrocardio-
grams (ECG) and serial biomarker (cardiac enzyme) measurements resulted in about 
2% discharge of patients who were later diagnosed with ACS, putting them at risk for 
higher mortality rates.4 Based on these data, it has been proposed to evaluate such 
patients with a rule-out strategy that involves stress testing and/or cardiac imaging, an 
approach that might be safer, but it can be time and money consuming. To address 
those issues, a single center randomized controlled trial evaluating the use of coronary 
computed tomography angiography (CCTA) versus nuclear stress studies in low risk 
patients presenting with chest pain in the ED has been published by Goldstein et al in 
2007.5 This trial randomized 197 patients and showed that the CCTA approach reduced 
time to diagnosis and cost compared to nuclear stress studies, while both approaches 
proved safe. Based on the results of that study, a multicenter trial, the CT-STAT trial 
was designed and its results will be briefly presented and discussed.
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ABBREVIATIONS
ACS = acute coronary syndrome
CAD = coronary artery disease
CCTA = coronary computed tomography 
angiography
ECG = electrocardiogram
ED = emergency department
ICA = invasive coronary angiography
MACE = major adverse cardiac events
MPI = myocardial perfusion imaging
SPECT = single-photon emission 
computed tomography
TIMI = thrombolysis in myocardial 
infarction (risk score)
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D E S I G N
The CT-STAT trial study was a multicenter, randomized, 
comparative effectiveness trial comparing a diagnostic ap-
proach including CCTA to an approach including rest-stress 
myocardial perfusion imaging (MPI) for evaluation of low 
risk patients with acute chest pain in 16 hospital emergency 
departments.
PA T I E N T S
Patients included in the study were all patients who 
presented in the EDs complaining of acute chest pain and 
considered to be low to intermediate risk patients (normal 
or nondiagnostic ECG, TIMI risk score 4) and they were 
randomized to either CCTA or rest-stress MPI. Serial enzyme 
measurements were carried out in all patients. Exclusion 
criteria comprised known CAD, elevated serum biomarkers, 
ischemic ECG changes, previously known cardiomyopathy with 
ejection fraction <45%, contraindication to iodinated contrast 
material and/or beta blockers, atrial fibrillation or markedly 
irregular rhythm, BMI 39 Kg/m2, elevated serum creatinine 
OHYHOV !PJGO&7 LPDJLQJRUFRQWUDVWDGPLQLVWUDWLRQ
within the past 48 hours.
E N D P O I N T S
The primary endpoint was diagnostic efficiency, defined as 
time to diagnosis (time from randomization to announcement 
of the test results to the ED physician). Secondary endpoints 
included ED costs of care and safety. Safety was defined as 
absence of major adverse cardiac events (MACE) over the 
following 6 months in patients considered to have a normal 
or near normal CCTA or MPI.
C C T A
Imaging was performed on CCTA scanners available in 
each institution including 64- to 320-slice scanners. Coronary 
artery stenoses were evaluated per segment and were reported 
as follows: 0 = no stenosis, 1 = 1-25% stenosis, 2 = 25-50% 
stenosis, 3 = 51-70% stenosis, 4 = 71-99% stenosis and 5 = 
total occlusion.
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Rest imaging studies were performed after enrolment and 
stress testing was done only if rest studies were normal, includ-
ing either treadmill exercise or pharmacologic (adenosine 
or dipyridamole) stress MPI. Myocardial perfusion imaging 
results were classified as normal, probably normal, equivocal, 
probably abnormal, or abnormal, based on perfusion imaging 
as well as on response to stress (symptoms, ECG changes, 
hemodynamics).
C L I N I C A L  D E C I S I O N S
In the CCTA arm patients with no stenoses or stenoses 
0-25% and calcium score <100 Agatston units were dis-
FKDUJHG3DWLHQWVZLWKVWHQRVHV!ZHUHUHIHUUHGIRULQYD-
sive coronary angiography (ICA). Patients with intermediate 
OHVLRQVRUFDOFLXPVFRUH!$JDWVWRQXQLWVRUXQLQWHUSUHW-
able scans were recommended to cross over for an MPI test. 
In the MPI arm patients with normal or probably normal 
tests were discharged, patients with ischemic ECG changes, 
elevated biomarkers and abnormal or equivocal MPI were to 
be referred for admission and/or ICA.
R E S U L T S
A total of 361 patients had a CCTA and 338 an MPI test. 
Of the CCTA patients, CAD was ruled out in 297 patients 
(82.2%), significant CAD was detected in 13 patients (3.6%), 
intermediate stenosis (25-70%) was found in 37 patients 
(10.2%) and uninterpretable scans had 14 patients (3.9%). Of 
the patients discharged based on CCTA findings no patient 
died or had a late ACS during a 6-month follow-up. Among 
the 338 MPI patients, index testing was normal or probably 
normal in 304 patients (89.9%). In the 6-month follow-up, no 
patient died or had post discharge ACS. There were no differ-
ences between the groups concerning the clinical outcomes. 
Concerning the diagnostic efficiency, the CCTA strategy was 
associated with a 54% reduction in time to diagnosis, median 
2.9 hours (2.1-4) vs median 6.2 hours (4.2-19) in the MPI 
group. Concerning total ED costs, in the CCTA group cost 
was reduced by 38.2%, median $2137 (1660-3077) vs median 
$3458 (2900-4297) in the MPI group. The cost of CCTA and 
nuclear test per se was similar ($507 vs$538). No significant 
differences were found concerning safety and both methods 
can be considered safe. Lastly in terms of radiation exposure, 
the CCTA group patients were exposed to significantly less 
radiation with a median of 11.5 mSv (6.8-16.8) versus median 
12.8 mSv (11.6-13.9) (p=0.02) in the MPI group.
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The first conclusion that can be drawn from this study is 
that both strategies (CCTA and rest-stress MPI) can safely be 
applied in low to intermediate risk patients presenting with 
acute chest pain in the EDs and the great majority of those 
patients can be safely discharged, based on either of the tests 
results. Secondly, this multicenter randomized trial confirms 
earlier reports5 demonstrating that the CCTA approach is asso-
ciated with significant (54%) reduction in time to diagnosis and 
significant (38.2%) in total ED costs, compared to MPI, even 
though, this test alone was not definite in 14% of the patients.
There are some points though, that have to be pointed out. 
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In the CT-STAT trial the rest-stress MPI protocol has been 
used and that might have increased both time to diagnosis and 
cost in the MPI arm. In recent years stress-only MPI protocols 
have successfully been evaluated.6 Several technical advances 
are nowadays improving the ability of single-photon emission 
CT (SPECT) MPI to diagnose ischemia faster and include 
ultrafast cameras that enable rest and stress imaging to each 
patient be performed in less than 5 min.7 Alternatively, an 
exercise ECG stress test alone (without imaging) could be 
feasible for safely discharging low risk acute chest pain patients 
and such a strategy has not been evaluated in this study.8 In 
the CT-STAT trial the diagnostic efficiency of an exercise 
ECG stress test alone, or stress echocardiography have not 
been evaluated. We also have to keep in mind that the results 
of the study are only applicable to the subset of patients that 
were included in the trial (low to intermediate risk acute chest 
pain patients suitable for CCTA) and can not be generalized 
to the whole ED chest pain population (for example patients 
with known CAD).
In summary, the CT-STAT trial provides further evidence 
for the CCTA’s excellent negative predictive value in patients 
at low risk for an ACS and low to intermediate risk for having 
CAD, and points out that it can be a particularly useful tool in 
the ED setting. Both the anatomic diagnostic strategy (CCTA) 
and physiologic stress imaging strategy (MPI) yield similar 
outcomes with respect to predicting cardiac events, and can 
be used for safely discharging patients with acute chest pain 
from the ED.
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